Valve Disease, Heart
Conditions
Brief summary
This registry is being conducted to support ongoing post-market surveillance activities.
Interventions
Surgical heart valve repair products.
Surgical heart valve replacement products.
Sponsors
Study design
Eligibility
Inclusion criteria
1. Patient or legally authorized representative provides written authorization and/or consent per institution and geographical requirements 2. Patient has or is intended to receive or be treated with an eligible product 3. Patient is within enrollment window of treatment/therapy received at the time of their initial Registry enrollment, or meets criteria for retrospective enrollment
Exclusion criteria
1. Patient who is, or is expected to be, inaccessible for follow-up 2. Patient prohibited from participation by local law 3. Patient is currently enrolled in or plans to enroll in any concurrent investigational drug and/or device study that may confound results
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Identify unique failure modes | 10 years |
| Identify trends in adverse device effects | 10 years |
Countries
Austria, Belgium, France, Germany, Greece, Italy, Netherlands, Spain, Switzerland, United States